Literature DB >> 22227113

Dual probe DNA capture for sensitive real-time PCR detection of Cryptosporidium and Giardia.

Suzanne Stroup1, Siripong Tongjai, Ndealilia Swai, Athanasia Maro, Gibson Kibiki, Eric R Houpt.   

Abstract

Nucleic acid amplification for the enteropathogens Cryptosporidium and Giardia is complicated by low target template concentrations and PCR inhibitors. In this work we designed dual capture oligonucleotides for both Cryptosporidium and Giardia 18S rRNA targets which when utilized during DNA extraction from stool improved the limit of detection of our multiplex PCR assay by 1-2 logs, to as little as 10 cysts. When applied to clinical specimens, the method improved the real-time PCR C(T) by an average of 10.7 ± 9.7 cycles. This work provides a highly sensitive protocol for Cryptosporidium and Giardia when limit of detection is of utmost importance.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22227113      PMCID: PMC3319247          DOI: 10.1016/j.mcp.2011.12.003

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  9 in total

1.  Cryptosporidiosis surveillance--United States 1999-2002.

Authors:  Michele C Hlavsa; John C Watson; Michael J Beach
Journal:  MMWR Surveill Summ       Date:  2005-01-28

2.  Real-time PCR detection and speciation of Cryptosporidium infection using Scorpion probes.

Authors:  Suzanne E Stroup; Shantanu Roy; John Mchele; Venance Maro; Simon Ntabaguzi; Abdullah Siddique; Gagandeep Kang; Richard L Guerrant; Beth D Kirkpatrick; Ronald Fayer; Joel Herbein; Honourine Ward; Rashidul Haque; Eric R Houpt
Journal:  J Med Microbiol       Date:  2006-09       Impact factor: 2.472

3.  Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test.

Authors:  Duncan Whitney; Joel Skoletsky; Kent Moore; Kevin Boynton; Lisa Kann; Randall Brand; Sapna Syngal; Michael Lawson; Anthony Shuber
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

4.  Giardiasis surveillance--United States, 1998-2002.

Authors:  Michele C Hlavsa; John C Watson; Michael J Beach
Journal:  MMWR Surveill Summ       Date:  2005-01-28

5.  Detection of diarrhoea-causing protozoa in general practice patients in The Netherlands by multiplex real-time PCR.

Authors:  R ten Hove; T Schuurman; M Kooistra; L Möller; L van Lieshout; J J Verweij
Journal:  Clin Microbiol Infect       Date:  2007-08-21       Impact factor: 8.067

6.  Multiplex real-time PCR assay using Scorpion probes and DNA capture for genotype-specific detection of Giardia lamblia on fecal samples.

Authors:  Cherie T Ng; Carol A Gilchrist; Ariel Lane; Shantanu Roy; Rashidul Haque; Eric R Houpt
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

7.  Closing the diarrhoea diagnostic gap in Indian children by the application of molecular techniques.

Authors:  S S R Ajjampur; P Rajendran; S Ramani; I Banerjee; B Monica; P Sankaran; V Rosario; R Arumugam; R Sarkar; H Ward; G Kang
Journal:  J Med Microbiol       Date:  2008-11       Impact factor: 2.472

8.  Development of a PCR protocol for sensitive detection of Cryptosporidium oocysts in water samples.

Authors:  D W Johnson; N J Pieniazek; D W Griffin; L Misener; J B Rose
Journal:  Appl Environ Microbiol       Date:  1995-11       Impact factor: 4.792

9.  Evaluation of a commercially available enzyme-linked immunosorbent assay for Giardia lamblia antigen in stool.

Authors:  D G Addiss; H M Mathews; J M Stewart; S P Wahlquist; R M Williams; R J Finton; H C Spencer; D D Juranek
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

  9 in total
  7 in total

Review 1.  The impoverished gut--a triple burden of diarrhoea, stunting and chronic disease.

Authors:  Richard L Guerrant; Mark D DeBoer; Sean R Moore; Rebecca J Scharf; Aldo A M Lima
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-12-11       Impact factor: 46.802

Review 2.  Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.

Authors:  Jaco J Verweij; C Rune Stensvold
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 3.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.

Authors:  William Checkley; A Clinton White; Devan Jaganath; Michael J Arrowood; Rachel M Chalmers; Xian-Ming Chen; Ronald Fayer; Jeffrey K Griffiths; Richard L Guerrant; Lizbeth Hedstrom; Christopher D Huston; Karen L Kotloff; Gagandeep Kang; Jan R Mead; Mark Miller; William A Petri; Jeffrey W Priest; David S Roos; Boris Striepen; R C Andrew Thompson; Honorine D Ward; Wesley A Van Voorhis; Lihua Xiao; Guan Zhu; Eric R Houpt
Journal:  Lancet Infect Dis       Date:  2014-09-29       Impact factor: 25.071

4.  Recombinase polymerase amplification-based assay to diagnose Giardia in stool samples.

Authors:  Zachary Austin Crannell; Miguel Mauricio Cabada; Alejandro Castellanos-Gonzalez; Ayesha Irani; Arthur Clinton White; Rebecca Richards-Kortum
Journal:  Am J Trop Med Hyg       Date:  2014-12-15       Impact factor: 2.345

5.  Overview on Cryptosporidium bovis and Its Effect on Calves in Some Governorates in Egypt.

Authors:  Amer R Abdelaziz; Amin Tahoun; Hanem El-Sharkawy; Moustafa M Abd El-Salam; Mohammed Alorabi; Ahmed M El-Shehawi; Rasha A El Meghanawy; Essam E Toukhy; Ahmed M Abd El-Salam; Shimaa S G Sorour
Journal:  J Trop Med       Date:  2022-05-31

6.  A Proposed Target Product Profile and Developmental Cascade for New Cryptosporidiosis Treatments.

Authors:  Christopher D Huston; Thomas Spangenberg; Jeremy Burrows; Paul Willis; Timothy N C Wells; Wesley van Voorhis
Journal:  PLoS Negl Trop Dis       Date:  2015-10-08

7.  An Improved PCR-RFLP Assay for Detection and Genotyping of Asymptomatic Giardia lamblia Infection in a Resource-Poor Setting.

Authors:  Yoursry Hawash; M M Ghonaim; S S Al-Shehri
Journal:  Korean J Parasitol       Date:  2016-02-26       Impact factor: 1.341

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.